A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This study has patients responding to two sets of surveys that will tell their doctor or nurse about their readiness to begin self-injection. In addition, patients will have their self-injection observed and evaluated on up to three visits
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
RRMS patient with treatment-naïve or treatment-experienced
Male or Female, 18 years of age or older, with diagnosis of RRMS
Naive to treatment or previously treated with an IFN.
Not eligible for treatment based on clinical criteria and current indication.
Unable to respond to surveys or provide informed consent.